Atria Investments’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-8,873	Closed	-$1.39M	–	757
2020 Q4	$1.39M	Buy	8,873 +82	+0.9%	+$10.5K	0.03%	548
2020 Q3	$1.01M	Buy	+8,791	New	+$948K	0.03%	576
2020 Q2	–	Sell	-6,174	Closed	-$554K	–	807
2020 Q1	$554K	Buy	6,174 +490	+9%	+$48.1K	0.04%	331
2019 Q4	$615K	Buy	5,684 +2,909	+105%	+$311K	0.02%	707
2019 Q3	$272K	Sell	2,775 -1,536	-36%	-$173K	0.01%	749
2019 Q2	$470K	Buy	4,311 +2,114	+96%	+$272K	0.02%	603
2019 Q1	$297K	Sell	2,197 -154	-7%	-$19.1K	0.01%	708
2018 Q4	$229K	Sell	2,351 -503	-18%	-$59.5K	0.01%	764
2018 Q3	$397K	Buy	2,854 +122	+4%	+$15.3K	0.02%	671
2018 Q2	$339K	Buy	2,732 +488	+22%	+$57K	0.01%	699
2018 Q1	$250K	Buy	2,244 +98	+5%	+$11.7K	0.01%	735
2017 Q4	$257K	Buy	2,146 +324	+18%	+$39.5K	0.01%	706
2017 Q3	$256K	Buy	+1,822	New	+$248K	0.01%	658
2017 Q2	–	Sell	-2,456	Closed	-$298K	–	801
2017 Q1	$298K	Sell	2,456 -224	-8%	-$28.9K	0.02%	517
2016 Q4	$328K	Buy	2,680 +429	+19%	+$52.5K	0.03%	444
2016 Q3	$276K	Buy	+2,251	New	+$290K	0.03%	421